Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall oxycontinOxyContin maker Purdue Pharma has targeted specific doctors to increase sales of its’ drug by supplying its’ sales team with information on OxyContin intended to allow OxyContin to become a top seller according to critics. Purdue Pharma used a strategy to obtain information on OxyContin from a specialized research company that was then given to its’ sales field representatives. The field reps were then equipped with specific information on OxyContin on prescribing methods of doctors in their territory. According to a doctor and critic of OxyContin, “when and OxyContin salesman walks in the door, he knows more about my prescribing than I do,” (AP, 8/18/03).
The information on OxyContin maker Purdue Pharma shows that the company offered very generous salaries for the sales reps to get OxyContin sales to take off. In 2000, the company had OxyContin sales of over $1 billion, showing that the specific information on OxyContin worked. Although pushing sales is what drug companies do, Purdue did not fulfill its responsibility to give adequate information on OxyContin regarding the risks of the drugs, which must be done with a powerful narcotic such as OxyContin.
The company that makes the pain relief drug OxyContin, Purdue Pharma LP, agreed Thursday to pay $600 million as a penalty for misleading and defrauding consumers and physicians about the addictive properties of its product. Another $34.5 million in pen...
Legislation promoted by Rep. Frank R. Wolf (R-Va.) and attached to a multi-department appropriations bill was passed last year with little notice, but this year, the U.S. Food and Drug Administration and many drug makers and doctors objected to its ren...
Purdue Pharma’s popular and controversial prescription drug OxyContin has avoided being named in a certification of a class action lawsuit claiming harm, including addiction.
OxyContin contains a very strong narcotic pain reliever similar t...